ELECTRONIC CIGARETTES AND CARDIOVASCULAR HEALTH: CURRENT EVIDENCE AND POLICY IN POLAND
Abstract
The increasing prevalence of electronic cigarette (e-cigarette) use during the past decade has generated significant concern among public health professionals. Although e-cigarettes are often marketed as safer alternatives to conventional tobacco products, emerging evidence demonstrates that aerosolized compounds produced during vaping may exert adverse effects on cardiovascular health. This review aims to summarize the current understanding of how substances released during vaping affect the cardiovascular system, with an emphasis on molecular mechanisms, clinical findings, and epidemiological data. Additionally, the paper examines the regulatory environment in Poland and compares it to broader European Union (EU) legislation. Despite the absence of combustion-related toxins, e-cigarette aerosols contain nicotine, aldehydes, volatile organic compounds, and heavy metals, all of which can induce oxidative stress, inflammation, and endothelial dysfunction. The available evidence indicates that long-term e-cigarette use is associated with increased cardiovascular risk. Therefore, comprehensive regulation, public education, and ongoing research are essential to mitigate the potential health burden associated with vaping.
References
Alzahrani, T., Pena, I., Temesgen, N., & Glantz, S. A. (2018). Association between electronic cigarette use and myocardial infarction. American Journal of Preventive Medicine, 55(4), 455–461.
Ambrose, J. A., & Barua, R. S. (2004). The pathophysiology of cigarette smoking and cardiovascular disease. Journal of the American College of Cardiology, 43(10), 1731–1737.
Benowitz, N. L. (2009). Pharmacology of nicotine: Addiction, smoking-induced disease, and therapeutics. Annual Review of Pharmacology and Toxicology, 49(1), 57–71.
Benowitz, N. L., & Fraiman, J. B. (2017). Cardiovascular effects of electronic cigarettes. Nature Reviews Cardiology, 14(8), 447–456.
Boas, Z., Gupta, P., Moheimani, R. S., Bhetraratana, M., & Middlekauff, H. R. (2020). E-cigarette use and its impact on arterial stiffness and endothelial function: A systematic review. Vascular Medicine, 25(2), 134–145.
Carnevale, R., Sciarretta, S., Violi, F., & Nocella, C. (2016). Acute impact of e-cigarette smoking on oxidative stress and vascular function. European Heart Journal, 37(48), 3729–3737.
European Commission. (2024). Tobacco Products Directive (2014/40/EU) and related legislation. Retrieved from https://health.ec.europa.eu/
Fetterman, J. L., Keith, R. J., Palmisano, J., et al. (2018). Flavorings in tobacco products induce endothelial dysfunction. Arteriosclerosis, Thrombosis, and Vascular Biology, 38(7), 1607–1615.
Lee, W. H., Ong, S. G., Zhou, Y., Tian, L., & Bae, H. R. (2019). Modeling cardiovascular risks of e-cigarette use. Cell Stem Cell, 24(6), 808–821.
Ministry of Health of the Republic of Poland. (2025). National tobacco control policy report. Warsaw: Government Printing Office.
Ndunda, P. M., & Muutu, T. M. (2019). Electronic cigarettes and risk of myocardial infarction: Insights from a systematic review. American Journal of Medicine, 132(3), 268–275.
Simons, S., Kleinhans, L., & Hagedorn, C. (2022). Metal exposure through electronic cigarettes: Implications for cardiovascular health. Environmental Health Perspectives, 130(4), 46001–46012.
Skotsimara, G., Antonopoulos, A. S., Oikonomou, E., et al. (2019). Cardiovascular effects of electronic cigarettes: A systematic review and meta-analysis. European Journal of Preventive Cardiology, 26(11), 1219–1228.
Sleiman, M., Logue, J. M., Montesinos, V. N., et al. (2016). Emissions from electronic cigarettes: Key parameters affecting the release of harmful chemicals. Environmental Science & Technology, 50(17), 9644–9651.
Strongin, R. M. (2019). E-cigarette chemistry and analytical detection. Annual Review of Analytical Chemistry, 12, 23–39.
Uchida, K. (1999). Role of acrolein in oxidative stress and inflammation. Chemical Research in Toxicology, 12(3), 179–188.
World Health Organization. (2023). Global status report on noncommunicable diseases 2023. Geneva: WHO Press.
Copyright (c) 2025 Bartosz Zwoliński, Wiktor Kubik, Wiktor Werenkowicz, Jan Nowak, Agata Król, Kacper Sukiennicki, Wirginia Bertman, Natalia Kołdej, Zuzanna Kępczyńska, Katarzyna Szewczyk, Kamil Borysewicz, Klaudia Romejko, Barbara Kujawa
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
